BIO
Bio-Rad Laboratories A·NYSE
--
--(--)
--
--(--)
BIO fundamentals
Bio-Rad Laboratories A (BIO) Revenue Breakdown: Q3 2025 Business & Regional Performance
Bio-Rad Laboratories A (BIO) reported total revenue of 653.00M USD in Q3 2025, with its core business segment Life Science contributing 40.09%. Regionally, United States remained the largest market, accounting for 41.35% of total revenue. Explore Bio-Rad Laboratories A's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Bio-Rad Laboratories A (BIO) reported total revenue of 653.00M USD in Q3 2025, with its core business segment Life Science contributing 40.09%. Regionally, United States remained the largest market, accounting for 41.35% of total revenue. Explore Bio-Rad Laboratories A's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What does Bio-Rad Laboratories A do and what are its main business segments?What were the key takeaways from Bio-Rad Laboratories A's earnings call?What were the key takeaways from Bio-Rad Laboratories A’s earnings call?What is Bio-Rad Laboratories A's latest dividend and current dividend yield?What guidance did Bio-Rad Laboratories A's management provide for the next earnings period?What is the market's earnings forecast for Bio-Rad Laboratories A next quarter?What is the revenue and EPS growth rate for Bio-Rad Laboratories A year over year?What factors drove the changes in Bio-Rad Laboratories A's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
